ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CVSG Cvs Group Plc

950.00
1.00 (0.11%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cvs Group Plc LSE:CVSG London Ordinary Share GB00B2863827 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.00 0.11% 950.00 951.00 954.00 996.00 941.00 996.00 585,309 16:29:55
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Veterinary Svcs-animal Specs 608.3M 41.9M 0.5843 16.26 681.27M

CVS Group plc Conclusion of CMA process, acquisition and trading (9258Q)

01/07/2022 7:00am

UK Regulatory


Cvs (LSE:CVSG)
Historical Stock Chart


From Apr 2022 to Apr 2024

Click Here for more Cvs Charts.

TIDMCVSG

RNS Number : 9258Q

CVS Group plc

01 July 2022

1 July 2022

CVS Group Plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Conclusion of CMA process through disposal, further acquisition and trading update

CVS, the AIM-quoted veterinary group and one of the UK's leading providers of integrated veterinary services, is pleased to announce that the CMA investigation into its acquisition of Quality Pet Care Limited (trading as The Vet) is now complete. The Initial Enforcement Order, imposed by the CMA on 22 September 2021, ceased to be in force on 27 June 2022. CVS completed the sale of Quality Pet Care Limited on 30 June 2022 for cash proceeds of c.GBP9m, thereby recognising an impairment of c. GBP12m which will be reported as an exceptional item.

In addition, the Board is also pleased to announce that on 10 June 2022, CVS acquired the entire share capital of OCVC Limited, trading as Old Courts Veterinary Centre, a two-site veterinary practice in North Lincolnshire, for consideration of c. GBP3m. The consideration was funded from the Group's cash balances. The Group has significant headroom in its bank facilities which, together with existing cash resources, is available to fund further organic investments and acquisitions.

CVS is pleased to confirm that current trading remains in line with management expectations for the full financial year.

The Group will issue a pre-close trading statement on 28 July 2022. Full year results for the financial year to 30 June 2022 are expected to be released on 22 September 2022.

This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR"), encompassing information relating to trading for the Company's current financial year, and is disclosed in accordance with the Company's obligations under UK MAR. This announcement is being made on behalf of the Company by the directors named below.

Contacts:

 
CVS Group plc                                             via MHP Communications 
Richard Fairman, CEO 
Jenny Farrer, Company Secretary 
Singer Capital Markets (Nominated Adviser 
 & Broker)                                                +44 20 7496 3000 
Aubrey Powell / Jen Boorer / Rachel Hayes 
MHP Communications (Financial PR)                         +44 20 3128 8549 
Andrew Jaques / Simon Hockridge / Rachel 
 Farrington / Charles Hirst 
 

About CVS Group plc ( www.cvsukltd.co.uk )

CVS Group is an AIM-quoted fully-integrated provider of veterinary services in the UK, with practices in the Netherlands and the Republic of Ireland. CVS is focused on providing high quality clinical services to its customers and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group has c.500 veterinary practices across its three markets, including eight specialist referral hospitals and 35 dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties), Crematoria (providing pet cremation and clinical waste disposal for CVS and third-party practices), Buying Groups and the Group's online retail business ("Animed Direct").

The Group employs c.7,900 personnel, including c.2,100 veterinary surgeons and c.2,900 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCSDDESSEESEDM

(END) Dow Jones Newswires

July 01, 2022 02:00 ET (06:00 GMT)

1 Year Cvs Chart

1 Year Cvs Chart

1 Month Cvs Chart

1 Month Cvs Chart

Your Recent History

Delayed Upgrade Clock